Northern Trust
BBOT

Northern Trust’s BridgeBio Oncology BBOT Stock Holding History

Northern Trust’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42M Buy
186,482
+84,224
+82% +$703K ﹤0.01% 3328
2026
Q1 		$915K Buy
102,258
+44,224
+76% +$475K ﹤0.01% 3379
2025
Q4 		$727K Sell
58,034
-37,923
-40% -$460K ﹤0.01% 3514
2025
Q3 		$1.11M Buy
+95,957
New +$1,000K ﹤0.01% 3352

Other funds holding BBOT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Northern Trust's BBOT Position: Q2 2026 in Review

Northern Trust increased its BridgeBio Oncology (BBOT) stake by 82% in Q2 2026, buying an estimated $703K and bringing the position to 186,482 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3328.

Northern Trust first reported a position in BBOT in Q3 2025 and has held it in 4 quarters since. 57 funds tracked by Wall St. Rank hold BBOT as of Q2 2026.

  • Northern Trust held 186,482 shares of BridgeBio Oncology worth $1.42M as of Q2 2026.
  • Northern Trust bought 84,224 BridgeBio Oncology shares in Q2 2026, an estimated $703K.
  • BridgeBio Oncology made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3328 holding.
  • Northern Trust first reported a position in BridgeBio Oncology in Q3 2025 and has held it in 4 quarters since.
  • 57 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.